RBI Monetary Policy | Just like the Fed, an RBI pivot remains elusive for Dalal Street
The MPC has delivered on the expectations as far as the quantum of the rate hike is concerned as it raised the repo rate to 6.25 percent from 5.9 percent earlier but the pivot on future rate hikes remained elusive
World’s best performing large stock market is set to see record foreign outflows
World-beating returns was not enough for foreign investors who pulled out money in large amounts thanks to rising global interest rates and a weakening local currency.
Pivot Powell to China's comeback: 4 global themes that will define investing in 2023
Equities may see a rout while bonds may emerge bigger in the "year of the yield", predict global investment banks
Why is ICICI Prudential MF doubling down on battered Nykaa?
The asset manager has snapped up 11.1 million shares in Nykaa’s parent since November 10. That’s roughly 16 percent of the shares sold since the end of the lock-in period for pre-IPO investors.
Fear index for stock market hits 14-month low as investor confidence builds up
The volatility gauge has fallen 83 percent from the record high of 86.63 touched on March 24, 2020, which also marked the bottom for the COVID-19 linked crash in the global stock markets.
List of FIIs seeking an out from NSE continues to grow longer
The latest is Morgan Stanley, which is seeking to sell 7-10 lakh shares of NSE through the auction process with a base price of Rs 2,750-2,800. This is at a steep discount of 9-15% over the last available unofficial quote. Also, the number of foreign direct and portfolio investors exiting the exchange itself is increasing.
Buccaneering traders bet Nifty rally has more legs to run on
In 2022, Indian stocks have outperformed amid continued buying from domestic institutional and retail investors, given the resilient outlook for the economy
Q2 review | IT earnings better than feared but road ahead bumpy
The commentary from the management of most major IT companies betrayed a level of uncertainty in their assessment of the demand environment, something not seen in previous earnings calls
Diagnostic giant warns cash-burning startups they have got it all wrong
Backed by deep-pocketed venture capitalists and private equity funds, health technology startups have sprouted in the diagnostics sector over the past five years, hoping to disrupt the existing status quo through low-cost testing procedures
Worries over UPL's bulging debt fail to enthuse investors despite big-bang private equity placement
The restructuring exercise has given UPL net proceeds of $259 million, which brokerage firm Prabhudas Lilladher believes will be used towards paring down its debt levels going ahead.
Exclusive | US FDA finds procedural issues at Lupin’s Nagpur injectables plant
Lupin, in an exchange filing on October 30 acknowledging the receipt of the form 482, said that the inspection pertained to pre-approval of its unit two.
Cipla Q2 preview | Consolidated net profit likely to rise 9% YoY
In the year-ago quarter, Cipla benefitted from the surge in sales of COVID-19-related drugs
How long will US Fed keep raising the interest rate?
Economic data over the past few months have showed little sign of stress in the US economy
Sun Pharma’s specialty drugs bet is beginning to pay off
Sun Pharmaceutical’s foray into specialty drugs was in some ways driven by an existential threat posed by rising competition to its generic drug business in the US. In the September quarter, it reported sales of $200 million from specialty drugs in the US, up 27.5 percent YoY
Nykaa’s new CTO aims to embrace crypto, metaverse to boost user engagement
The former Amazon executive said that in the coming weeks, he will interact with Nykaa's stakeholders to develop more efficient and effective platforms for its customers.
Preview | UPL to see strong growth in Q2 earnings driven by India operations
The company will report its quarterly earnings on November 1, just days after it announced a massive restructuring of its business to unlock value.
Q2 Preview | Sun Pharma consolidated net may drop 4% on high R&D costs
Sun Pharmaceutical’s consolidated revenues, however, are expected to rise 13.2 percent on a year-on-year basis aided by growth in US specialty products and domestic formulations portfolio
Inflation fight likely to trigger Rs 27,000 crore in losses for PSU refiners in Q2
The cumulative net loss of OMCs in the September quarter will be the highest since the June quarter of 2012-13 when they reported a combined loss of Rs 40,536 crore
Dr Reddy’s Q2 preview: Pharma major likely to report sharp drop in net profit on weak US biz
Dr Reddy’s North American operations will set the tone for the September quarter performance, as likely price erosion will trigger a decline in sales on a year-on-year basis
PharmEasy’s annus horribilis may get worse before it gets better
The funding winter confronting startups this year owing to surging global interest rates, the capitulation of technology stocks amid fears of a recession in the West and increasing investor dislike for loss-making, cash-burning companies has hit the online pharmacy giant hard.
Earnings, global factors key to a good show this Samvat
As investors look forward to the new samvat, many of the same issues will continue to plague global markets including surging inflation, a slowing global economy and heightened geopolitical uncertainties
RIL gains as co to demerge, list Jio Financial Services
On October 21, RIL announced that shareholders will get one share of Jio Financial Services for every one share held in the company by them.
ICICI Bank sizzles in muhurat trading post strong Q2 earnings
Shares of ICICI Bank have risen 23 percent so far in 2022, outperforming the Nifty Bank index as well as the Nifty 50 index.
Muhurat trading ends on a strong note; here are the factors that drove market
Analysts said the Nifty 50 will face tough resistance at 17,850-17,900 levels, and sustainability of the rally will hinge on the index crossing that mark.
- RBI Monetary Policy: From repo rate hike to GDP and inflation forecast: Key highlights Watch more
- ChatGPT crosses one million users | This bot answers everything — what's this AI from Elon Musk? Watch more
- How Does Digi Yatra Work? | Here's how you can use your face as your boarding pass at Delhi airport! Watch more
- How Retail CBDC is different from UPI | Explained Watch more
- Why Debt Funds Should Be A Part Of Your Portfolio | Mutual Funds | Invesco Watch more